Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

NCT06367517 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Orbitopathy, Graves
Thyroid Eye Disease
Ophthalmopathy

Interventions

DRUG: Tocilizumab

Sponsor

Medical University of Warsaw